Goldenwell Biotech, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
Goldenwell Biotech's 2024 10-K filing reveals continued losses, minimal revenue, and substantial doubt about its ability to continue as a going concern.
OTC.Pink
Goldenwell Biotech's 2023 annual report reveals ongoing losses and a dependence on future financing, raising concerns about the company's ability to continue as a going concern.